Vitamin D inhibits the growth of and virulence factor gene expression by Porphyromonas gingivalis and blocks activation of the nuclear factor kappa B transcription factor in monocytes

J Periodontal Res. 2016 Jun;51(3):359-65. doi: 10.1111/jre.12315. Epub 2015 Aug 22.

Abstract

Background and objective: Increasing evidence suggests that 1,25-dihydroxyvitamin D3 (1,25(OH)2 D3 ), a fat-soluble secosteroid hormone, has a positive impact on periodontal health through diverse mechanisms. The present study was aimed at investigating the effect of 1,25(OH)2 D3 on the growth of and virulence factor gene expression by the periodontopathogenic bacterium Porphyromonas gingivalis. The effect of 1,25(OH)2 D3 on P. gingivalis-mediated activation of nuclear factor kappa B (NF-κB) transcription factor in monocytes was also assessed.

Material and methods: A broth microdilution assay was used to determine the antibacterial activity of 1,25(OH)2 D3 . The modulation of virulence factor gene expression in P. gingivalis was assessed by quantitative reverse transcription-polymerase chain reaction. NF-κB activation was assessed using a human monocytic cell line stably transfected with a luciferase reporter containing NF-κB binding sites.

Results: Minimal inhibitory concentrations of 1,25(OH)2 D3 against P. gingivalis ranged from 3.125 to 6.25 μg/mL. Moreover, a partial synergistic effect was observed when 1,25(OH)2 D3 was used in association with metronidazole. 1,25(OH)2 D3 attenuated the virulence of P. gingivalis by reducing the expression of genes coding for important virulence factors, including adhesins (fimA, hagA and hagB) and proteinases (rgpA, rgpB and kgp). 1,25(OH)2 D3 dose-dependently prevented P. gingivalis-induced NF-κB activation in a monocyte model.

Conclusion: Our study suggested that 1,25(OH)2 D3 selectively inhibits the growth of and virulence factor gene expression by P. gingivalis, in addition to attenuating NF-κB activation by this periodontopathogen. This dual action on P. gingivalis and the inflammatory response of host cells may be of particular interest with a view to developing a novel and inexpensive preventive/therapeutic strategy.

Keywords: Porphyromonas gingivalis; chronic periodontitis; cytokine; host modulatory therapy; macrophage.

MeSH terms

  • Adhesins, Bacterial / drug effects
  • Adhesins, Bacterial / genetics
  • Bacterial Proteins / drug effects
  • Bacterial Proteins / genetics
  • Cell Line, Tumor / drug effects
  • Cysteine Endopeptidases / drug effects
  • Cysteine Endopeptidases / genetics
  • Drug Combinations
  • Fimbriae Proteins / drug effects
  • Fimbriae Proteins / genetics
  • Gene Expression / drug effects*
  • Gingipain Cysteine Endopeptidases
  • Humans
  • Lectins / drug effects
  • Lectins / genetics
  • Metronidazole / pharmacology
  • Microbial Sensitivity Tests
  • Monocytes / metabolism*
  • NF-kappa B / drug effects*
  • NF-kappa B / metabolism
  • Peptide Hydrolases / drug effects
  • Peptide Hydrolases / genetics
  • Porphyromonas gingivalis / drug effects*
  • Porphyromonas gingivalis / genetics*
  • Porphyromonas gingivalis / metabolism
  • Transcription Factors / drug effects*
  • Transcription Factors / genetics
  • U937 Cells / drug effects
  • Virulence Factors / genetics*
  • Vitamin D / analogs & derivatives
  • Vitamin D / antagonists & inhibitors*

Substances

  • Adhesins, Bacterial
  • Bacterial Proteins
  • Drug Combinations
  • Gingipain Cysteine Endopeptidases
  • HagB protein, Porphyromonas gingivalis
  • Lectins
  • NF-kappa B
  • Transcription Factors
  • Virulence Factors
  • dihydroxy-vitamin D3
  • fimbrillin
  • hemagglutinin A, Porphyromonas gingivalis
  • Vitamin D
  • Metronidazole
  • Fimbriae Proteins
  • Peptide Hydrolases
  • Cysteine Endopeptidases